1.09
price down icon7.63%   -0.09
after-market Dopo l'orario di chiusura: 1.08 -0.01 -0.92%
loading
Precedente Chiudi:
$1.18
Aprire:
$1.1
Volume 24 ore:
763.49K
Relative Volume:
1.09
Capitalizzazione di mercato:
$108.99M
Reddito:
$100.56M
Utile/perdita netta:
$-119.05M
Rapporto P/E:
-0.8862
EPS:
-1.23
Flusso di cassa netto:
$-231.16M
1 W Prestazione:
-18.05%
1M Prestazione:
-22.70%
6M Prestazione:
-74.17%
1 anno Prestazione:
-81.49%
Intervallo 1D:
Value
$1.09
$1.145
Intervallo di 1 settimana:
Value
$1.09
$1.355
Portata 52W:
Value
$1.09
$6.78

Alector Inc Stock (ALEC) Company Profile

Name
Nome
Alector Inc
Name
Telefono
415-231-5660
Name
Indirizzo
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Name
Dipendente
238
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-05
Name
Ultimi documenti SEC
Name
ALEC's Discussions on Twitter

Confronta ALEC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALEC
Alector Inc
1.09 108.99M 100.56M -119.05M -231.16M -1.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 125.55B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 67.78B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 36.24B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.99B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.77B 3.81B -644.79M -669.77M -6.24

Alector Inc Stock (ALEC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-17 Downgrade Mizuho Outperform → Neutral
2024-12-16 Downgrade Stifel Buy → Hold
2024-12-04 Downgrade BofA Securities Neutral → Underperform
2024-11-29 Reiterato H.C. Wainwright Buy
2024-11-26 Downgrade Morgan Stanley Equal-Weight → Underweight
2023-12-14 Aggiornamento Stifel Hold → Buy
2023-12-12 Iniziato Deutsche Bank Buy
2023-09-25 Iniziato Goldman Sell
2023-09-22 Iniziato Cantor Fitzgerald Overweight
2023-01-06 Downgrade BofA Securities Buy → Neutral
2022-09-09 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-07-07 Iniziato Mizuho Buy
2022-04-13 Iniziato Goldman Sell
2022-03-08 Downgrade Stifel Buy → Hold
2021-09-27 Iniziato William Blair Outperform
2021-01-15 Ripresa BofA Securities Buy
2020-06-24 Iniziato H.C. Wainwright Buy
2020-04-28 Iniziato Goldman Buy
2020-03-06 Iniziato Citigroup Buy
2020-02-27 Iniziato Barclays Overweight
2020-02-19 Iniziato Stifel Buy
2019-11-21 Iniziato BTIG Research Buy
2019-03-04 Iniziato Barclays Overweight
2019-03-04 Iniziato BofA/Merrill Buy
2019-03-04 Iniziato Morgan Stanley Overweight
2019-03-04 Iniziato SVB Leerink Outperform
Mostra tutto

Alector Inc Borsa (ALEC) Ultime notizie

pulisher
04:23 AM

Frontotemporal Dementia Pipeline 2025: Key Companies, MOA, - openPR.com

04:23 AM
pulisher
03:02 AM

Brokerages Set Alector, Inc. (NASDAQ:ALEC) Price Target at $3.50 - Defense World

03:02 AM
pulisher
Mar 31, 2025

Alector stock hits 52-week low at $1.24 amid market challenges - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Reduces Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World

Mar 30, 2025
pulisher
Mar 30, 2025

Alector, Inc. (NASDAQ:ALEC) Shares Sold by Charles Schwab Investment Management Inc. - The AM Reporter

Mar 30, 2025
pulisher
Mar 28, 2025

Alector Announces Resignation of Chief Medical Officer - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Appoints New Chief Medical Officer - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Provides Executive Leadership Update - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

Alector Names Neurology Expert as CMO Amid Crucial Phase 3 Dementia Trial - Stock Titan

Mar 28, 2025
pulisher
Mar 25, 2025

Alector Cuts Staff Again, This Time Laying Off 13% of Workforce - BioSpace

Mar 25, 2025
pulisher
Mar 21, 2025

Alector, Inc. (NASDAQ:ALEC) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st

Mar 21, 2025
pulisher
Mar 19, 2025

Alector stock hits 52-week low at $1.29 amid sharp annual decline - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

Alector at Virtual CNS Forum: Advancing Neurodegenerative Treatments - Investing.com

Mar 18, 2025
pulisher
Mar 13, 2025

Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection Point (NASDAQ:ALEC) - Seeking Alpha

Mar 13, 2025
pulisher
Mar 12, 2025

Mizuho’s latest rating for ALEC stock - Knox Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Alector at Leerink Global Healthcare Conference: Strategic Advances in Neurodegeneration - Investing.com India

Mar 11, 2025
pulisher
Mar 10, 2025

Alector announces workforce reduction to cut costs By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

Alector announces workforce reduction to cut costs - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Alector to Cut 13% of Workforce - MarketWatch

Mar 10, 2025
pulisher
Mar 10, 2025

Have Alector Insiders Been Selling Stock? - simplywall.st

Mar 10, 2025
pulisher
Mar 09, 2025

Alector, Inc. (NASDAQ:ALEC) Receives $3.75 Consensus Target Price from Analysts - Defense World

Mar 09, 2025
pulisher
Mar 07, 2025

Alector assumed with an Underweight at Morgan Stanley - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Alector at TD Cowen Conference: Advancing Neurodegenerative Therapies By Investing.com - Investing.com UK

Mar 06, 2025
pulisher
Mar 05, 2025

Alector Executives Sell Shares to Satisfy Tax Obligations - TradingView

Mar 05, 2025
pulisher
Mar 04, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

William Blair Predicts Alector’s Q1 Earnings (NASDAQ:ALEC) - The AM Reporter

Mar 04, 2025
pulisher
Mar 03, 2025

Alector stock hits 52-week low at $1.54 amid sharp annual decline By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 02, 2025

Research Analysts Set Expectations for Alector Q1 Earnings - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

Earnings Update: Alector, Inc. (NASDAQ:ALEC) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Mar 01, 2025
pulisher
Feb 28, 2025

Alector (NASDAQ:ALEC) Receives "Buy" Rating from HC Wainwright - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Alector Full Year 2024 Earnings: Beats Expectations - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Alector’s Earnings Call: Progress Amid Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Alector (NASDAQ:ALEC) Releases Earnings Results, Beats Expectations By $0.59 EPS - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (ALEC) Shares Up Despite Recent Market Volatility - The News Heater

Feb 27, 2025
pulisher
Feb 27, 2025

Alector, Inc. (NASDAQ:ALEC) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Alector Inc Q4 2024 sees cautious market reaction By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising Clinical Advances - GuruFocus.com

Feb 27, 2025
pulisher
Feb 27, 2025

Alector: Q4 Earnings Snapshot - mySA

Feb 27, 2025
pulisher
Feb 27, 2025

The Bold Bet on Brain Health: Alector’s Race Against Time in Neurodegenerative Research - Smartphone Magazine

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (NASDAQ:ALEC): The Biotech Pioneering New Frontiers in Neurodegenerative Diseases - Jomfruland.net

Feb 27, 2025
pulisher
Feb 27, 2025

Alector beats Q4 estimates, shares edge higher By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Alector Inc (ALEC) Q4 2024 Earnings Call Highlights: Strong Cash Position and Promising ... - Yahoo Finance

Feb 27, 2025
pulisher
Feb 27, 2025

Alector, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Alector’s 2024 Financial Results and Clinical Advancements - TipRanks

Feb 27, 2025

Alector Inc Azioni (ALEC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):